IFNAR1 and COVID-19: In this study, using the nucleoside-modified mRNA-LNP vaccine platform, which have shown powerful and very promising results in the development of a vaccine against COVID-19 (17, –, 25), we demonstrate 100% protection of IFNAR−/− mice against lethal CCHFV infection.